ABVC BIOPHARMA, INC. quarterly report, Q2 FY2015

Filing identity and reporting period

Important identity mismatch: The supplied filing is for Ecology Coatings, Inc., not ABVC Biopharma, Inc. It is a Form 10-Q for the quarter ended March 31, 2015, filed May 15, 2015. The filing’s index also contains a conflicting “quarter ended June 30, 2014” reference. Financial statements are unaudited.

Ecology Coatings reported that after its Chapter 7 bankruptcy and fresh-start accounting in September 2014, it operated a website selling women’s apparel. The filing says post-bankruptcy results are not comparable with earlier results.

Financial results and position

MetricThree months ended March 31Six months ended March 31
Revenue$0 in 2015 and 2014$0 in 2015 and 2014
Operating expenses$840 in 2015; $30 in 2014$1,870 in 2015; $40 in 2014
Net loss$840 in 2015; $30 in 2014$1,870 in 2015; $40 in 2014
Operating cash flow$0 for six months in 2015; $(40) in 2014
  • At March 31, 2015, reported cash was $0; accounts receivable and property and equipment were also $0. Intangible assets were $64,594.
  • Reported liabilities were $35,900: accrued expenses of $19,900, a $7,000 note payable, and a $9,000 related-party note payable. The $7,000 note carried no interest, was due September 24, 2015, and was stated not to be in default.
  • Shareholders’ equity was reported at $28,694. Common shares outstanding were 54,593,032; 271 preferred shares were also reported outstanding.
  • No interest expense, interest paid, or income taxes paid were reported. Gross margin and a current ratio are not meaningfully calculable from the reported figures.

Changes, outlook, and risks

  • Year-over-year expenses and losses increased, which management attributed to administrative activity and operating the website. Management noted that the 2014 comparison period was during bankruptcy proceedings; post-bankruptcy fresh-start results are not directly comparable with prior operating results.
  • The company reported no revenue in either period and provided no specific financial guidance. Management said additional capital was needed for working capital, with no assurance financing would be available.
  • The filing states that limited post-bankruptcy operations and a working capital deficit raise substantial doubt about the company’s ability to continue as a going concern.
  • Disclosure controls and procedures were deemed ineffective because the small finance staff lacked segregation of duties. No changes to internal control over financial reporting were reported for the quarter.
  • The filing reports no legal proceedings, lease commitments, or off-balance-sheet arrangements. It says bankruptcy-related contingencies had been settled. Potential use of tax-loss carryforwards may be limited under Section 382.

Key facts investors should verify

  • Confirm whether this filing is relevant to ABVC Biopharma: the registrant named throughout is Ecology Coatings, Inc.
  • Resolve apparent financial-statement inconsistencies: inventory is listed at $795, while total current assets are shown as $0; the balance sheet’s reported total assets remain $64,594.
  • Confirm the reporting-period references, given the March 31, 2015 financial statements and the conflicting June 30, 2014 index heading.
  • Assess the company’s ability to raise working capital, sustain operations, and meet the $7,000 note’s stated September 2015 maturity.
  • Consider the disclosed ineffective controls and the lack of revenue when evaluating the reliability and prospects of the reported business.